Analysts See $0.05 EPS for Wright Medical Group N.V. (WMGI)

January 21, 2018 - By Vivian Currie

 Analysts See $0.05 EPS for Wright Medical Group N.V. (WMGI)

Analysts expect Wright Medical Group N.V. (NASDAQ:WMGI) to report $0.05 EPS on February, 20.They anticipate $0.11 EPS change or 183.33 % from last quarter’s $-0.06 EPS. WMGI’s profit would be $5.22 million giving it 115.30 P/E if the $0.05 EPS is correct. After having $-0.16 EPS previously, Wright Medical Group N.V.’s analysts see -131.25 % EPS growth. The stock increased 1.14% or $0.26 during the last trading session, reaching $23.06. About 1.86M shares traded or 86.41% up from the average. Wright Medical Group N.V. (NASDAQ:WMGI) has risen 49.62% since January 21, 2017 and is uptrending. It has outperformed by 32.92% the S&P500.

Wright Medical Group N.V. (NASDAQ:WMGI) Ratings Coverage

Among 18 analysts covering Wright Medical Group (NASDAQ:WMGI), 14 have Buy rating, 0 Sell and 4 Hold. Therefore 78% are positive. Wright Medical Group had 37 analyst reports since August 20, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets with “Buy” on Thursday, November 2. The stock of Wright Medical Group N.V. (NASDAQ:WMGI) has “Hold” rating given on Thursday, August 20 by Needham. As per Tuesday, September 5, the company rating was maintained by Jefferies. Sterne Agee CRT initiated the shares of WMGI in report on Wednesday, November 4 with “Buy” rating. The stock of Wright Medical Group N.V. (NASDAQ:WMGI) has “Outperform” rating given on Thursday, September 3 by Leerink Swann. The rating was upgraded by Jefferies to “Buy” on Monday, November 30. The rating was downgraded by Bank of America on Tuesday, April 11 to “Neutral”. The stock has “Hold” rating by Piper Jaffray on Wednesday, September 2. Northland Capital maintained the stock with “Buy” rating in Wednesday, September 2 report. The stock of Wright Medical Group N.V. (NASDAQ:WMGI) has “Neutral” rating given on Tuesday, January 3 by Guggenheim.

Wright Medical Group N.V., a medical device company, designs, makes, markets, and sells extremities and biologics products.in the United States, Europe, the Middle East, Africa, and internationally. The company has market cap of $2.41 billion. The firm offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It currently has negative earnings. It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries.

More notable recent Wright Medical Group N.V. (NASDAQ:WMGI) news were published by: Globenewswire.com which released: “Wright Medical Group NV to Present at Jefferies 2017 London Healthcare Conference” on October 25, 2017, also Seekingalpha.com with their article: “Wright Medical Group NV (WMGI) Q1 2017 Results – Earnings Call Transcript” published on May 04, 2017, Globenewswire.com published: “Wright Medical Group NV Reports 2017 Second Quarter Financial Results” on August 02, 2017. More interesting news about Wright Medical Group N.V. (NASDAQ:WMGI) were released by: Globenewswire.com and their article: “Wright Medical Group NV Announces Acquisition of IMASCAP SAS” published on December 14, 2017 as well as Seekingalpha.com‘s news article titled: “Back To The Future With Wright Medical” with publication date: February 23, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: